1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. SEXUALLY TRANSMITTED DISEASE (STD) TESTING MARKET BY DISEASE TYPE
5.1. Introduction
5.2. Chlamydia
5.3. Gonorrhea
5.4. Herpes simplex virus
5.5. Syphilis
5.6. Human papillomavirus (HPV)
5.7. Others
6. SEXUALLY TRANSMITTED DISEASE (STD) TESTING MARKET BY TESTING LOCATION
6.1. Introduction
6.2. Laboratory testing
6.3. Point of care (POC) testing
7. SEXUALLY TRANSMITTED DISEASE (STD) TESTING MARKET BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. USA
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. Germany
7.4.2. France
7.4.3. United Kingdom
7.4.4. Spain
7.4.5. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Others
7.6. Asia Pacific
7.6.1. China
7.6.2. India
7.6.3. Japan
7.6.4. South Korea
7.6.5. Indonesia
7.6.6. Thailand
7.6.7. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Abbott Laboratories
9.2. Becton Dickinson Company
9.3. Biomérieux, Inc.
9.4. Bio-Rad Laboratories Inc.
9.5. Diasorin Molecular LLC
9.6. Hologic Inc.
9.7. Roche Holdings AG
9.8. Thermo Fisher Scientific (Affymetrix)
10. APPENDIX
10.1. Currency
10.2. Assumptions
10.3. Base and Forecast Years Timeline
10.4. Key benefits for the stakeholders
10.5. Research Methodology
10.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES